National
New group joins fight against workplace discrimination
Freedom to Work seeks passage of ENDA in two years
Tico Almeida (photo by Scott Henrichsen)
A new group has formed to push for passage of the Employment Non-Discrimination Act and its leaders hope to disband after achieving their primary legislative goal in just two years.
The organization, called Freedom to Work, is headed by Tico Almeida, a civil rights litigator who served as ENDA’s lead counsel on the U.S. House Education & Labor Committee from 2007 to 2010.
In an interview with the Washington Blade, Almeida, who’s gay, said he’s personally committed to the passage of ENDA because he’s worked on workplace discrimination issues for several years and cares deeply about the problem.
“My legal career has been about workplace justice issues — not just for LGBT people — but on wage and hour issues, on immigrant workplace issues,” Almeida said. “My passion lies in workplace fairness and that’s what I want to be working in the next few years.”
Joe Racalto, Freedom to Work’s vice president for public policy and development, comes to the organization after working as a senior policy adviser for more than a decade for gay Rep. Barney Frank (D-Mass.).
“Few, if any, issues have dominated my professional and personal life like ENDA,” Racalto said. “I am joining the team at Freedom to Work because I don’t want LGBT workplace issues to get left behind any longer.”
Discriminating against workers — or even firing them — is legal on the basis of sexual orientation in 29 states and on the basis of gender identity in 35 states.
As it currently stands, ENDA would provide federal protections against this kind of discrimination in most situations against LGBT people in the private and public workforce. The legislation is sponsored by Frank in the House and Sen. Jeff Merkley (D-Ore.) in the Senate.
Almeida said the first step for Freedom to Work before the start of the next Congress over the course of the next 14 months is building up its speaker’s bureau of LGBT people who’ve experienced workplace discrimination.
The personal stories of these people in the workplace, Almeida said, will help match statistics and studies showing the problem of workplace discrimination “with compelling stories to personalize the issue.”
“We don’t have that many recent compelling stories to tell — especially compared to the successful advocacy that there was done to repeal ‘Don’t Ask, Don’t Tell’ in which dozens and dozens of service members were telling their stories to national media, to newspapers both local and national throughout the course of the year to build up toward repeal,” Almeida said.
Jarrod Chlapowski, development and outreach director for Servicemembers United, said educational and personal stories helped in the effort to repeal “Don’t Ask, Don’t Tell” and should contribute to the campaign to pass ENDA.
“In every movement, real momentum begins when the political climate is not so favorable and transformational figures choose to lay the basic educational groundwork from which a critical mass for change can be achieved,” Chlapowski said. “This was the model used by Servicemembers United in the movement to repeal [‘Don’t Ask, Don’t Tell’], and I am pleased and exhilarated that lessons and tactics learned in the [‘Don’t Ask, Don’t Tell’] repeal fight are finally being utilized in the movement for full workplace equality.”
Chlapowski is a member of Freedom to Work’s national advisory board and said he’s honored to be part of the organization as it “moves forward with its ambitious vision.”
The organization already has one LGBT individual as a member of its speaker’s bureau who’s experienced workplace discrimination and is calling for passage of ENDA.
Ronald Crump, a sergeant for the Los Angeles Police Department, is a founding member of the bureau and says he experienced discrimination while on the job as a police officer.
After his supervisor targeted him with anti-gay harassment and insults, Crump complained to his superiors, but they responded with further retaliation.
“I was retaliated against and received a transfer that amounted to a demotion after I complained to the L.A.P.D. that my direct supervisor was harassing me for being gay,” Crump said.
According to Crump, he was told by his supervisor: “I was a religion major at Liberty University — Jerry Falwell would roll over in his grave if he knew I hired you.”
Because such discrimination is illegal under California state law, Crump was able to take his claims to a jury in a Los Angeles courthouse and prevailed earlier this year. However, the same legal action wouldn’t be possible in many places in the country.
“I am grateful that earlier this year I got my day in court to prove my case of retaliation, and a jury of my peers agreed with me and awarded a significant verdict,” Crump said. “That was possible only because California laws guarantee LGBT employees the freedom to work without discrimination. If I had worked as a police officer in Philadelphia, Miami, St. Louis or Houston, I never would have gotten my day in court. That’s why we need ENDA.”
Highlighting these stories is what Freedom to Work is focusing on over the course of the 112th Congress. Almeida said he thinks passing ENDA before the end of next year will be a “Hail Mary” and the work for the time being will be on spreading personal stories “so that we start the next Congress much better prepared.”
“And by telling those stories, we think we will change hearts and minds and convince even more Americans — who already overwhelmingly support the bill — but even more Americans that this is the right policy and convince more lawmakers that they should vote ‘yes,'” Almeida said.
Asked when he thinks ENDA will become law, Almeida made a pledge for his organization: Freedom to Work will dissolve after ENDA has been passed into law and is hoping to do so before its two-year anniversary.
“We will exist for the sole purpose of increasing public education about LGBT workplace discrimination and for passing ENDA, and will disband after the statute goes into effect,” Almeida said. “So, it is our goal and would be an enormous success if we dissolve Freedom to Work by our two-year anniversary in the fall of 2013.”
Almeida acknowledged that passage of ENDA might not happen by that time, but said he thinks passage would be a “solid accomplishment” even if it occurred at a later time.
“If it took three years or four years, I still think that would be a solid accomplishment and we would still be very happy with the outcome and dissolve the organization that way,” Almeida said.
Any oversight role that would be needed after ENDA is passed, Almeida said, would be fulfilled by the private bar and other LGBT groups.
“It will always be the case for all civil rights statutes that courts will roll back advances, and Congress may have to come out and fix or improve statutes, and there are a large number of civil rights groups within the LGBT community, outside of it, lawyers’ groups that monitor those things and work on enforcement,” Almeida said.
One issue with ENDA that has instigated discussion — even heated conflict — within the LGBT community is the inclusion of gender identity language in the legislation.
In 2007, Frank dropped the gender identity protections in the legislation after he determined the votes were lacking in the 110th Congress to pass an inclusive version of the legislation.
The House passed the measure 235-184, but the removal of the language caused a firestorm in the LGBT community. The legislation never saw action in the Senate.
Almeida called the inclusion of both sexual orientation and gender identity language “absolutely essential” ingredients.
“It’s a matter of fairness, it’s a matter of unity and solidarity in our community and it’s the best policy,” Almeida said.
Concurrent with the goal of passing ENDA, Freedom to Work also aims to convince President Obama to take administrative action to address workplace discrimination against LGBT people.
Along with other advocates, the organization is pushing for an executive order prohibiting federal money from going to contractors and suppliers that don’t have their own non-discrimination protections based on sexual orientation and gender identity.
“In the next year, one of our main policy areas of focus will be encouraging the Obama administration to create and amend the executive order for federal contractors,” Almeida said. “We will do public education through op-eds, blogs, other social media to increase awareness about how such an executive order will save U.S. taxpayer money and protect LGBT Americans’ freedom to work for federal contractors.”
The order has been seen as an interim alternative to passing ENDA as long as Republicans remain in control of the U.S. House, but Almeida said the legislation and the order are “completely complementary.”
“That is a goal worth pursuing in and of itself because the executive order will have real enforcement powers that the Department of Labor can use on behalf of real life victims of workplace discrimination even before ENDA passes, and even after ENDA passes,” Almeida said.
Having both the order and law in place would provide two avenues for LGBT people seeking remedies for discrimination they’ve experienced in the workplace.
The directive would provide recourse through the Department of Labor while ENDA would provide recourse through the U.S. Equal Employment Opportunity Commission. Other workers — including racial minorities and women —have both options to protect them.
Almeida added the order will “build political momentum” and raise the visibility of LGBT workplace discrimination issues to “make getting ENDA through Congress even easier.”
The Obama administration hasn’t said whether it would be open to issuing such an executive order. Still, Almeida said he’s “optimistic” the administration will come through with the directive before the end of the Obama’s first term.
“I’m optimistic because of the Obama administration’s strong record on LGBT issues in the past three years and I’m optimistic because this politically is far easier than some of the things they have already done,” Almeida said.
U.S. Supreme Court
Nine trans activists arrested outside Supreme Court
Gender Liberation Movement organized demonstration against Skrmetti ruling
On Friday afternoon, nine transgender organizers and allies were arrested on the steps of the U.S. Supreme Court for blocking the street and protesting the recent U.S. v. Skrmetti ruling.
The ruling, decided 6-3 by the conservative majority on Wednesday, upheld Tennessee’s ban on gender-affirming care for minors. The decision will allow states to pass laws restricting gender-affirming care for minors and further minimizes bodily autonomy.
The nine arrested were part of a larger group of more than 30 protesters wearing colors of the trans Pride flag— pink, blue, and white, — standing outside of the nation’s highest court. Organizers unfurled large cloths in pink, blue, and white, shared personal testimonies about how their gender-affirming care was a matter of life and death, released pink and blue smoke, and saw nine trans participants take their hormone replacement therapy.
The protest was led by the Gender Liberation Movement, an organization that “builds direct action, media, and policy interventions centering bodily autonomy, self-determination, the pursuit of fulfillment, and collectivism in the face of gender-based sociopolitical threats.” Among the nine arrested was GLM co-founder Raquel Willis.
Before being arrested, Willis spoke to multiple media outlets, explaining that this decision was an overreach of power by the Supreme Court.
“Gender-affirming care is sacred, powerful, and transformative. With this ruling in U.S. v. Skrmetti, we see just how ignorant the Supreme Court is of the experiences of trans youth and their affirming families,” said Willis. “Everyone deserves the right to holistic healthcare, and trans youth are no different. We will continue to fight for their bodily autonomy, dignity, and self-determination just like previous generations. No court, no law, no government gave us our power, and none can take it away.”
GLM co-founder Eliel Cruz also spoke to media outlets about the Skrmetti ruling, calling it “a historical moment of fascist attacks,” and encouraged the LGBTQ community to “organize and fight back.”
“As a cisgender man, I stand in solidarity with the trans community during these escalating attacks on their safety, well-being, right to exist in this world, and ability to live a future free of violence,” Cruz said. “I’m enraged at the Supreme Court’s decision to uphold a ban on gender-affirming care for youth. My heart hurts for the families and young people who this will negatively impact and harm.”
The Washington Blade reached out to Capitol Police for comment.
A spokesperson said the nine activists were arrested for violating D.C. Code §22-1307 — “Crowding, Obstructing, or Incommoding” — on First Street, N.E., after receiving three warnings.
National
FDA approves new twice-yearly HIV prevention drug
Experts say success could inhibit development of HIV vaccine
The U.S. Food and Drug Administration (FDA) on June 18 approved a newly developed HIV/AIDS prevention drug that only needs to be taken by injection once every six months.
The new drug, lenacapavir, which is being sold under the brand name of Yeztugo by the pharmaceutical company Gilead Sciences that developed it, is being hailed by some AIDS activists as a major advancement in the years-long effort to end the HIV/AIDS epidemic in the U.S. and worldwide.
Although HIV prevention drugs, known as pre-exposure prophylaxis medication or PrEP, have been available since 2012, they initially required taking one or more daily pills. More recently, another injectable PrEP drug was developed that required being administered once every two months.
Experts familiar with the PrEP programs noted that while earlier drugs were highly effective in preventing HIV infection – most were 99 percent effective – they could not be effective if those at risk for HIV who were on the drugs did not adhere to taking their daily pills or injections every two months. Experts also point out that large numbers of people at risk for HIV, especially members of minority communities, are not on PrEP and efforts to reach out to them should be expanded.
“Today marks a monumental advance in HIV prevention,” said Carl Schmid, executive director of the D.C.-based HIV + Hepatitis Policy Institute, in a statement released on the day the FDA announced its approval of lenacapavir.
“Congratulations to the many researchers who spent 19 years to get to today’s approval, backed up by the long-term investment needed to get the drug to market,” he said.
Schmid added, “Long-acting PrEP is now not only effective for up to six months but also improves adherence and will reduce HIV infections – if people are aware of it and payers, including private insurers, cover it without cost-sharing as a preventive service.”
Schmid and others monitoring the nation’s HIV/AIDS programs have warned that proposed large scale cuts in the budget for the U.S. Centers for Disease Control and Prevention by the administration of President Donald Trump could seriously harm HIV prevention programs, including PrEP-related efforts.
“Dismantling these programs means that there will be a weakened public health infrastructure and much less HIV testing, which is needed before a person can take PrEP,” Schmid said in his statement.
“Private insurers and employers must also immediately cover Yeztugo as a required preventive service, which means that PrEP users should not face any cost-sharing or utilization management barriers,” he said.
In response to a request by the Washington Blade for comment, a spokesperson for Gilead Sciences released a statement saying the annual list price per person using Yeztugo in the U.S. is $28,218. But the statement says the company is working to ensure that its HIV prevention medication is accessible to all who need it through broad coverage from health insurance companies and some of its own support programs.
“We’ve seen high insurance coverage for existing prevention options – for example, the vast majority of consumers have a $0 co-pay for Descovy for PrEP in the U.S. – and we are working to ensure broad coverage for lenacapavir [Yeztugo],” the statement says. It was referring to the earlier HIV prevention medication developed by Gilead Sciences, Descovy.
“Eligible insured people will get help with their copay,” the statement continues. “Gilead’s Advancing Access Copay Savings Program may reduce out-of-pocket costs to as little as zero dollars,” it says. “Then for people without insurance, lenacapavir may be available free of charge for those who are eligible, through Gilead’s Advancing Access Patient Assistance Program.”
Gilead Sciences has announced that in the two final trial tests for Yeztugo, which it describes as “the most intentionally inclusive HIV prevention clinical trial programs ever designed,” 99.9 percent of participants who received Yeztugo remained negative. Time magazine reports that among those who remained HIV negative at a rate of 100 percent were men who have sex with men.
Time also reports that some HIV/AIDS researchers believe the success of the HIV prevention drugs like Gilead’s Yeztugo could complicate the so-far unsuccessful efforts to develop an effective HIV vaccine.
To be able to test a potential vaccine two groups of test subjects must be used, one that receives the test vaccine and the other that receives a placebo with no drug in it.
With highly effective HIV prevention drugs now available, it could be ethically difficult to ask a test group to take a placebo and continue to be at risk for HIV, according to some researchers.
“This might take a bit of the wind out of the sails of vaccine research, because there is something so effective in preventing HIV infection,” Time quoted Dr. David Ho, a professor of microbiology, immunology, and medicine at New York’s Columbia University as saying.
National
Activists rally in response to Supreme Court ruling
‘We won’t bow to hatred: we outlive it’
Politicians, LGBTQ activists, and allies gathered at the Lutheran Church of the Reformation in the Capitol Hill neighborhood of Washington, D.C. on Wednesday following the ruling by the United States Supreme Court in the case of U.S. v. Skrmetti. The Supreme Court upheld a Tennessee ban on gender-affirming healthcare for transgender adolescents in a 6-3 decision.
A rally outside the U.S. Supreme Court was called for by the American Civil Liberties Union, Lambda Legal and other organizations following the high court ruling on Wednesday. However, due to a thunderstorm and flood watch, the scores of activists who were to attend the rally were directed to a Lutheran church down the street from the court. Undeterred, activists and community leaders were joined by U.S. Senators Ed Markey (D-Mass.) and Jeff Merkley (D-Ore.) for an indoor rally at the church.
“We know that freedom is not inevitable,” Markey told the crowd. “It is fought for by people who said ‘no’ in the face of health cuts, ‘no’ in the face of discrimination, ‘no’ in the face of invasive laws that ban life-saving and life-affirming healthcare and ‘no’ to this anti-justice, anti-freedom agenda.”
Also speaking at the rally was Deirdre Schifeling, chief political advocacy officer of the National ACLU.
“We believe transgender rights matter,” Schifeling stated. “Transgender kids matter and deserve love, support and the freedom to shape their own futures. I am still processing how the Supreme Court could disagree with such an obvious truth.”
“Today’s ruling shows us that unfortunately these attacks on our freedom will not end here,” Schifeling continued. “The Trump administration and extremist politicians across the country are continuing to target our right — our human right — to control our own bodies.”
“If politicians think that we are going to sit back and be defeated, that we are going to let them strip our rights and freedoms away without a fight, they’ve got another think coming,” Schifeling said. “We will never back down. We will never back down or give up. We will organize, we will mobilize and we will fight to protect trans rights in our communities, in our legislatures, in our elections, and in court rooms across the country.”
“Today, the highest court in this land decided that the bodily autonomy of trans youth, specifically trans youth of Tennessee and states with bans harming youth across the country do not matter,” said trans advocate Hope Giselle-Godsey.
“The opponents of trans equality think that today is a victory, but history will remember it as a moment that sharpened us and not silenced us,” Giselle-Godsey continued.
“So yes, today we grieve for the people in those states where those bans exist, but we grieve in motion,” Giselle-Godsey said. “To the system that thinks that it won today, just like every other time before: you will lose again. Because we won’t bow to hatred: we outlive it. We out-organize it. We out-love it. We are still here and we are not finished yet.”
Nine trans activists arrested outside Supreme Court
Norton reintroduces bill to ban discrimination against LGBTQ jurors in D.C. Superior Court
PHOTOS: Goodwin Living Pride Parade
More books for Pride month
Baltimore Orioles Pride Night set for June 25
Supreme Court upholds ban on transgender care for minors
Juvenile arrested for anti-gay assault in D.C.
New LGBTQ+ Archive to save scrubbed federal resources
PHOTOS: Baltimore Pride Parade
